title: The role of endothelial-to-mesenchymal transition in cancer progression.
abstract: Recent evidence has demonstrated that endothelial-to-mesenchymal transition (EndMT) may have a significant role in a number of diseases. Although EndMT has been previously studied as a critical process in heart development, it is now clear that EndMT can also occur postnatally in various pathologic settings, including cancer and cardiac fibrosis. During EndMT, resident endothelial cells delaminate from an organised cell layer and acquire a mesenchymal phenotype characterised by loss of cell-cell junctions, loss of endothelial markers, gain of mesenchymal markers, and acquisition of invasive and migratory properties. Endothelial-to-mesenchymal transition -derived cells are believed to function as fibroblasts in damaged tissue, and may therefore have an important role in tissue remodelling and fibrosis. In tumours, EndMT is an important source of cancer-associated fibroblasts (CAFs), which are known to facilitate tumour progression in several ways. These new findings suggest that targeting EndMT may be a novel therapeutic strategy, which is broadly applicable not only to cancer but also to various other disease states.
authors.affiliation: Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
authors.forename: S
authors.initials: S
authors.lastname: Potenta
authors.forename: E
authors.initials: E
authors.lastname: Zeisberg
authors.forename: R
authors.initials: R
authors.lastname: Kalluri
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D018450:Disease Progression; D042783:Endothelial Cells / Q000166:cytology / Q000473:pathology*; D005347:Fibroblasts / Q000473:pathology; D005355:Fibrosis; D006321:Heart / Q000196:embryology; D006801:Humans; D008648:Mesoderm / Q000166:cytology / Q000473:pathology*; D009206:Myocardium / Q000473:pathology; D009369:Neoplasms / Q000473:pathology*; D018919:Neovascularization, Physiologic; D015398:Signal Transduction
references.citation: Cancer Res. 2007 Nov 1;67(21):10123-8
references.pmid: 17974953
references.citation: Nat Cell Biol. 2000 Feb;2(2):84-9
references.pmid: 10655587
references.citation: Am J Anat. 1977 Jan;148(1):85-119
references.pmid: 842477
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 Jul;293(1):L1-8
references.pmid: 17384082
references.citation: Nat Rev Mol Cell Biol. 2006 Feb;7(2):131-42
references.pmid: 16493418
references.citation: J Clin Invest. 2007 Feb;117(2):482-91
references.pmid: 17273560
references.citation: Dev Biol. 1975 Jan;42(1):160-80
references.pmid: 1112439
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10623-8
references.pmid: 12963823
references.citation: Dev Biol. 1989 Aug;134(2):392-401
references.pmid: 2744239
references.citation: Nat Cell Biol. 2000 Feb;2(2):76-83
references.pmid: 10655586
references.citation: Development. 1997 Jul;124(13):2659-70
references.pmid: 9217007
references.citation: Nat Med. 2007 Aug;13(8):952-61
references.pmid: 17660828
references.citation: Circ Res. 2005 Sep 16;97(6):512-23
references.pmid: 16166562
references.citation: Nature. 2001 Nov 1;414(6859):105-11
references.pmid: 11689955
references.citation: Circ Res. 2002 Jun 14;90(11):1189-96
references.pmid: 12065322
references.citation: Circ Res. 2004 Apr 16;94(7):910-7
references.pmid: 14988227
references.citation: J Cell Biol. 2003 Jun 23;161(6):1163-77
references.pmid: 12810700
references.citation: J Am Soc Nephrol. 2008 Dec;19(12):2282-7
references.pmid: 18987304
references.citation: J Biol Chem. 2003 Jan 10;278(2):1303-9
references.pmid: 12417591
references.citation: Genes Dev. 2004 Jan 1;18(1):99-115
references.pmid: 14701881
references.citation: J Cell Biochem. 2007 Jul 1;101(4):816-29
references.pmid: 17243120
references.citation: Nat Rev Mol Cell Biol. 2002 Mar;3(3):155-66
references.pmid: 11994736
references.citation: Nat Rev Cancer. 2006 May;6(5):392-401
references.pmid: 16572188
references.citation: Anat Rec. 2000 Feb 1;258(2):119-27
references.pmid: 10645959
references.citation: Dev Biol. 2000 Jul 1;223(1):91-102
references.pmid: 10864463
references.citation: Circ Res. 2004 Sep 3;95(5):459-70
references.pmid: 15345668
references.citation: Circ Res. 2005 Nov 25;97(11):1093-107
references.pmid: 16306453
references.citation: Int J Exp Pathol. 2006 Dec;87(6):463-74
references.pmid: 17222214
references.citation: Exp Eye Res. 2006 Dec;83(6):1309-16
references.pmid: 16769055
references.citation: Nat Rev Mol Cell Biol. 2002 May;3(5):349-63
references.pmid: 11988769
references.citation: J Clin Invest. 2002 Aug;110(3):341-50
references.pmid: 12163453
references.citation: Biull Eksp Biol Med. 1988 Apr;105(4):501-3
references.pmid: 3359040
references.citation: Oncogene. 2005 Aug 29;24(37):5764-74
references.pmid: 16123809
references.citation: Anat Embryol (Berl). 2000 Feb;201(2):103-9
references.pmid: 10672362